CIK 0001367083
- Non-accelerated filer
- Smaller reporting company
Sonoma Pharmaceuticals, Inc.
Sign in to watch- Ticker
- SNOA
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680423298
- Phone
- +1 800-759-9305
- Business address
- 5445 CONESTOGA COURT, SUITE 150, BOULDER, CO, 80301
- Former names
- Oculus Innovative Sciences, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 86 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-09-06 | Birnbaum Jay E Director | Grant or award · Stock Option (Right to Buy) | +14,035 | 60,686 | ||
| 2013-08-16 | Schutz James J Chief Executive Officer | Purchase | +5,100 | $2.35 | $12K | 14,600 |
| 2012-12-10 | Alimi Hojabr Chief Executive Officer | Purchase | +3,000 | $0.64 | $2K | 1,028,550 |
| 2012-12-10 | Alimi Hojabr Chief Executive Officer | Purchase | +2,500 | $0.64 | $2K | 1,031,050 |
| 2012-12-07 | Alimi Hojabr Chief Executive Officer | Purchase | +1,000 | $0.65 | $650 | 1,026,750 |
| 2012-12-07 | Alimi Hojabr Chief Executive Officer | Purchase | +2,000 | $0.65 | $1K | 1,028,750 |
| 2012-12-07 | Alimi Hojabr Chief Executive Officer | Purchase | +2,200 | $0.65 | $1K | 1,030,950 |
| 2012-12-07 | Alimi Hojabr Chief Executive Officer | Purchase | +100 | $0.65 | $65 | 1,031,050 |
| 2012-12-06 | Alimi Hojabr Chief Executive Officer | Purchase | +1,000 | $0.63 | $626 | 1,012,250 |
| 2012-12-06 | Alimi Hojabr Chief Executive Officer | Purchase | +1,000 | $0.63 | $629 | 1,013,250 |
| 2012-12-06 | Alimi Hojabr Chief Executive Officer | Purchase | +3,000 | $0.63 | $2K | 1,016,250 |
| 2012-12-06 | Alimi Hojabr Chief Executive Officer | Purchase | +4,000 | $0.64 | $3K | 1,020,250 |
| 2012-11-09 | Schutz James J Chief Operating Officer | Purchase | +100 | $0.80 | $80 | 53,600 |
| 2012-11-09 | Schutz James J Chief Operating Officer | Purchase | +11,400 | $0.80 | $9K | 65,000 |
| 2012-11-09 | Schutz James J Chief Operating Officer | Purchase | +500 | $0.80 | $400 | 65,500 |
| 2012-11-09 | Schutz James J Chief Operating Officer | Purchase | +1,000 | $0.78 | $780 | 66,500 |
| 2012-10-01 | French Gregory M Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 527,555 | ||
| 2012-10-01 | Conley Richard K Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 545,678 | ||
| 2012-10-01 | Birnbaum Jay E Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 343,649 | ||
| 2012-10-01 | Alton Gregg H Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 305,405 |
Page 12 of 13 · 249 trades